We are live on ! Find out more
KMTS

Kestra Medical Technologies
KMTS

73 hedge funds and large institutions have $785M invested in Kestra Medical Technologies in 2025 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 25 increasing their positions, 8 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

213% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 8

58% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 19

16% more funds holding

Funds holding: 63 → 73 (+10)

1.73% more ownership

Funds ownership: 90.53% → 92.26% (+1.7%)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

30% less capital invested

Capital invested by funds: $1.12B → $785M (-$332M)

Holders
73
Holders Change
+10
Holders Change %
+15.87%
% of All Funds
0.96%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
30
Increased
25
Reduced
8
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$17.4M
2
EAM
Eventide Asset Management
Massachusetts
+$17.2M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$15.8M
4
Citadel Advisors
Citadel Advisors
Florida
+$12.6M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.8M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$21.2M
2
Millennium Management
Millennium Management
New York
-$8.91M
3
O
OrbiMed
New York
-$6.23M
4
PA
Perceptive Advisors
New York
-$4.98M
5
RSCM
Rock Springs Capital Management
Maryland
-$3.61M
Name Holding Trade Value Shares
Change 		Change in
Stake
TD Asset Management
26
TD Asset Management
Ontario, Canada
$1.31M -$302K -13,830 -15%
Alyeska Investment Group
27
Alyeska Investment Group
Illinois
$1.24M -$546K -25,000 -25%
GCM
28
Ghisallo Capital Management
Massachusetts
$1.24M – – –
UBS Group
29
UBS Group
Switzerland
$1.21M +$597K +27,329 +60%
SSA
30
Schonfeld Strategic Advisors
New York
$1.18M +$788K +36,110 +103%
Point72 Asset Management
31
Point72 Asset Management
Connecticut
$844K +$1.11M +50,900 New
Manulife (Manufacturers Life Insurance)
32
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$707K +$297K +13,599 +47%
Morgan Stanley
33
Morgan Stanley
New York
$690K +$805K +36,854 +770%
SAM
34
Sectoral Asset Management
Quebec, Canada
$580K +$764K +35,000 New
Millennium Management
35
Millennium Management
New York
$574K -$8.91M -408,255 -92%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$546K +$719K +32,936 New
SEI Investments
37
SEI Investments
Pennsylvania
$513K +$244K +11,185 +57%
LP
38
Longaeva Partners
Illinois
$510K +$396K +18,161 +144%
Barclays
39
Barclays
United Kingdom
$488K +$468K +21,459 +268%
Russell Investments Group
40
Russell Investments Group
United Kingdom
$385K +$106K +4,859 +26%
AC
41
Armistice Capital
New York
$379K +$226K +10,334 +83%
N
42
Nuveen
North Carolina
$284K +$375K +17,159 New
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
$279K +$368K +16,856 New
Goldman Sachs
44
Goldman Sachs
New York
$262K +$346K +15,830 New
JP Morgan Chase
45
JP Morgan Chase
New York
$256K +$338K +15,469 New
SPC
46
Sigma Planning Corp
Michigan
$253K +$333K +15,250 New
SFM
47
Soros Fund Management
New York
$249K – – –
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$200K +$263K +12,051 New
LIA
49
Limestone Investment Advisors
New York
$194K +$256K +11,712 New
Walleye Capital
50
Walleye Capital
New York
$166K +$218K +10,000 New
1
2
3 4

KMTS Hedge Fund Activity: Q2 2025 in Review

73 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Kestra Medical Technologies (KMTS) for Q2 2025, worth a combined $785M — down 30% from $1.12B a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new KMTS positions and 19 closed out — a net gain of 11 holders — while 25 added to existing stakes and 8 trimmed.

The largest buyer was BlackRock, adding an estimated $17.4M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $21.2M.

  • 73 institutional investors held Kestra Medical Technologies (KMTS) as of Q2 2025, up from 63 in Q1 2025.
  • Funds reported $785M of Kestra Medical Technologies stock for Q2 2025, down 30% quarter-over-quarter.
  • 30 funds opened new Kestra Medical Technologies positions in Q2 2025 and 19 closed out, a net change of +11 holders.
  • The largest Kestra Medical Technologies buyer in Q2 2025 was BlackRock, an estimated $17.4M added.
  • The largest Kestra Medical Technologies seller in Q2 2025 was T. Rowe Price Investment Management, an estimated $21.2M sold.

Based on aggregated 13F filings for Q2 2025.